Trial Profile
A retrospective study evaluating the vascular response of everolimus-eluting bioresorbable scaffold (BRS) struts deployed at bifurcation lesions using optical coherence tomography
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 29 Sep 2017
Price :
$35
*
At a glance
- Drugs Everolimus (Primary)
- Indications Coronary artery restenosis
- Focus Therapeutic Use
- 29 Sep 2017 New trial record